Market Tracker

06/29 4:09am ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

79.49
Delayed Data
As of Jun 28
 +4.88 / +6.54%
Today’s Change
62.12
Today|||52-Week Range
151.75
-24.12%
Year-to-Date

Today’s Trading

Previous close74.61
Today’s open76.23
Day’s range76.02 - 79.71
Volume1,585,069
Average volume (3 months)1,572,550
Market cap$12.1B
Dividend yield--
Data as of 4:00pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)-16.30%
Earnings growth (this year)-103.26%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+16.29%
P/E ratioNM
Price/Sales19.22
Price/Book5.02

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC-0.48-0.55%
INCYIncyte Corp+4.14+5.72%
MDVNMedivation Inc+1.18+2.08%
RDYDr.Reddy's Laborator...+1.23+2.57%
Data as of 4:02pm ET, 06/28/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)-$0.51
Annual revenue (last year)$872.2M
Annual profit (last year)-$171.8M
Net profit margin-19.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts